Protalex, Inc. · New Hope, PA United States ·(OTC: PRTX)
Company Description
View Protalex, Inc. Locations On A US Map
This link will open in a new window
Protalex is developing a technique called bioregulation to make drugs that control a disease instead of treating the symptoms after the disease has wreaked havoc on the body. The company's development programs target autoimmune diseases and inflammatory ailments. Lead drug candidate PRTX-100 is in early stage trials to target rheumatoid arthritis and idiopathic thrombocytopenic purpura (ITP), an autoimmune disorder characterized by excessive bleeding. Other potential disease targets include skin diseases psoriasis and pemphigus, inflammatory bowel condition Crohn's disease, and autoimmune disorders multiple sclerosis and lupus. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Protalex, Inc. Financials
| Company Type | Public - OTC: PRTX Single Location |
| Fiscal Year-End | May |
| 2009 Sales (mil.) | $0.0 |
| 2008 Employees | 8 |
Protalex, Inc. Executives
9 executives listed for Protalex, Inc.'s New Hope, PA location.
| Title | Name & Bio | Contact |
| Chairman | G. Kirk Raab | Network |
| VP, Finance, CFO, Treasurer, and Corporate Secretary | Marc Rose | Network |
| Medical Director | Edward Bernton | Network |
Competition
Competitive Landscape for Protalex, Inc.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Protalex, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
